Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 44

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 44
---
 shares then subject to outstanding stock appreciation rights previously granted and unexercised under the
2020 Plan, will be proportionally adjusted to the end that the same proportion of our issued and outstanding shares of Common Stock in
each instance shall remain subject to exercise at the same aggregate exercise price; subject to adjustments for any fractional shares
as described herein and provided, however, that the number of shares of Common Stock (or other securities or property) subject to any
award shall always be a whole number. In addition, the total number of shares of Common Stock that may be the subject of future grants
under the 2020 Plan, as well as any plan limits on the size of such grants will be adjusted and proportionately decreased as a result
of the Reverse Stock Split.

Effects of the Reverse Stock Split on Voting Rights.

Proportionate voting rights
and other rights of the holders of Common Stock would not be affected by the Reverse Stock Split (other than as a result of the treatment
of fractional shares). For example, a holder of 1% of the voting power of the outstanding Common Stock immediately prior to the effective
time of the Reverse Stock Split would continue to hold 1% of the voting power of the outstanding Common Stock after the Reverse Stock
Split.

<div align='center'>27</div>

Effects of the Reverse Stock Split on Regulatory Matters.

The Company is subject to
the periodic reporting and other requirements of the Exchange Act. The Reverse Stock Split will not affect the Company’s obligation
to publicly file financial and other information with the SEC.

Effects of the Reverse Stock Split on Authorized Share Capital.

The total number of shares
of capital stock that we are authorized to issue will not be affected alone by the Reverse Stock Split and will remain at 300,000,000
shares, consisting of 250,000,000 shares of Common Stock and 50,000,000 shares of Preferred Stock.

Treatment of Fractional Shares in the Reverse Stock Split

The Company does not intend
to issue fractional shares in the event that a stockholder owns a number of shares of Common Stock that is not evenly divisible by the
Reverse Stock Split ratio. If the Reverse Stock Split is effected, each fractional share of Common Stock will be:

| · | rounded up to the nearest whole share of Common Stock, if such shares of Common Stock are held directly; 
 or                                                                                                       |

| · | rounded down to the nearest whole share of Common Stock, if such shares are subject to an award granted 
 under the